Ladrx Corp (LADX) — SEC Filings
Ladrx Corp (LADX) — 13 SEC filings. Latest: 8-K (Jul 31, 2025). Includes 5 8-K, 4 10-Q, 2 10-K.
Overview
Ladrx Corp (LADX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Jul 31, 2025: On June 11, 2025, LadRx Corp (formerly CYTRX CORP) filed an 8-K report indicating potential triggering events that could accelerate or increase financial obligations. The filing also noted the departure of directors or certain officers, the election of new directors, and the appointment of new offic
Sentiment Summary
Across 13 filings, the sentiment breakdown is: 12 neutral, 1 mixed. The dominant filing sentiment for Ladrx Corp is neutral.
Filing Type Overview
Ladrx Corp (LADX) has filed 5 8-K, 4 10-Q, 2 10-K, 1 DEF 14A, 1 SC 13G/A with the SEC between Feb 2024 to Jul 2025.
Filings by Year
Recent SEC Filings (13)
| Date | Form | Description | Risk |
|---|---|---|---|
| Jul 31, 2025 | 8-K | LadRx Corp (LADX) Files 8-K on Financial Obligations & Officer Changes | medium |
| Jun 27, 2025 | 8-K | LadRx Corp. Files 8-K for "Other Event" | medium |
| May 14, 2025 | 10-Q | LadRx Corp Files Q1 2025 10-Q | low |
| Apr 16, 2025 | 8-K | LadRx Corp. Appoints New CEO, Board Changes | medium |
| Mar 28, 2025 | 10-K | LadRx Corp Files 2024 10-K | low |
| Nov 14, 2024 | 10-Q | LadRx Corp Files Q3 2024 10-Q | low |
| Oct 9, 2024 | 8-K | LadRx Corp Files 8-K on Shareholder Vote Matters | medium |
| Aug 20, 2024 | DEF 14A | LadRx Corp Files Definitive Proxy Statement | low |
| Aug 14, 2024 | 10-Q | LadRx Corp Files Q2 2024 10-Q | low |
| Jun 6, 2024 | 8-K | LadRx Corp. Enters and Terminates Material Agreements | medium |
| May 15, 2024 | 10-Q | LadRx Corp Files 10-Q for Period Ending March 31, 2024 | low |
| Mar 27, 2024 | 10-K | LadRx Corp Files 2023 Annual Report on Form 10-K | low |
| Feb 14, 2024 | SC 13G/A | SC 13G/A Filing |
Risk Profile
Risk Assessment: Of LADX's 12 recent filings, 0 were flagged as high-risk, 5 as medium-risk, and 7 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Dr. Steven G. Deitcher
- Dr. Richard L. Schilsky
Top Tags
10-Q (4) · biotech (4) · financials (3) · corporate-governance (2) · 10-K (2) · LadRx Corp (2) · financial-obligation (1) · management-change (1) · 8-K (1) · other-event (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Reporting Period | Q1 2025 | First quarter financial results |
| As of Date | 2025-03-31 | End of the reporting period |
| Filing Date | 2025-05-14 | Date the report was submitted to the SEC |
| Fiscal Year End | 2024-12-31 | Reporting period for the 10-K |
| SEC File Number | 000-15327 | Identifies the specific SEC filing for LadRx Corp. |
| Film Number | 241222530 | Internal SEC processing number for the filing. |
| Period End Date | 2024-03-31 | Reporting period for the 10-Q |
| Central Index Key | 0000799698 | Company's unique identifier |
| SIC Code | 2836 | Standard Industrial Classification for Biological Products |
Frequently Asked Questions
What are the latest SEC filings for Ladrx Corp (LADX)?
Ladrx Corp has 13 recent SEC filings from Feb 2024 to Jul 2025, including 5 8-K, 4 10-Q, 2 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of LADX filings?
Across 13 filings, the sentiment breakdown is: 12 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Ladrx Corp SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Ladrx Corp (LADX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Ladrx Corp?
Key financial highlights from Ladrx Corp's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for LADX?
The investment thesis for LADX includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Ladrx Corp?
Key executives identified across Ladrx Corp's filings include Dr. Steven G. Deitcher, Dr. Richard L. Schilsky.
What are the main risk factors for Ladrx Corp stock?
Of LADX's 12 assessed filings, 0 were flagged high-risk, 5 medium-risk, and 7 low-risk.
What are recent predictions and forward guidance from Ladrx Corp?
Forward guidance and predictions for Ladrx Corp are extracted from SEC filings as they are enriched.